Latest stories on AIFF
Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans as Commercial Expansion Accelerates
Business Insider64 · neutralproduct/pr
Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans as Commercial Expansion Accelerates
GlobeNewswire64 · neutralproduct/pr
Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform
Business Insider63 · neutralproduct/pr
Firefly (AIFF) ties its 200,000-scan Evoke network to NeuroSigma’s FDA-cleared Monarch ADHD therapy
MarketChameleon67 · bullishproduct/pr
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
GlobeNewswire67 · bullishproduct/pr
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
Business Insider67 · bullishproduct/pr
Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine
Business Insider63 · neutralproduct/pr
FIREFLY NEUROSCIENCE, INC. (AIFF) files 8-K
SEC 8-K50 · neutralgeneral
Firefly Neuroscience Expands Incentive Plan, Tightens Capital Structure
TipRanks42 · neutralgeneral
FIREFLY NEUROSCIENCE, INC. (AIFF) files 8-K
SEC 8-K50 · neutralgeneral
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes
Business Insider63 · neutralproduct/pr
Adobe: How AI Is Enhancing Its Business, Not Killing It
Seeking Alpha67 · bullishproduct/pr
FIREFLY NEUROSCIENCE, INC. (AIFF) files 8-K
SEC 8-K34 · bearishgeneral
Firefly Neuroscience Reassigns Former CTO to AI Leadership
TipRanks50 · neutralgeneral
FIREFLY NEUROSCIENCE, INC. (AIFF) files 8-K
SEC 8-K50 · neutralgeneral
Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD | AIFF Stock News
StockTitan67 · bullishproduct/pr